Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis

被引：5

作者：

Lam, Megan ^{[1
]}

Spuls, Phyllis I. ^{[2
]}

Leshem, Yael A. ^{[3
]}

Gerbens, Louise A. A. ^{[2
]}

Thomas, Kim S. ^{[4
]}

Arents, Bernd ^{[5
]}

Burton, Tim ^{[6
]}

Flohr, Carsten ^{[7
]}

Drucker, Aaron M. ^{[1
,8
,9
]}

机构：

[1] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada

[2] Univ Amsterdam, Dept Dermatol, Amsterdam UMC, Locat Acad Med Ctr,Amsterdam Public Hlth Infect &, Amsterdam, Netherlands

[3] Tel Aviv Univ, Petah Tikva & Sackler Fac Med, Div Dermatol, Rabin Med Ctr, Tel Aviv, Israel

[4] Univ Nottingham, Sch Med, Ctr Evidence Based Dermatol, Nottingham, England

[5] Dutch Assoc People Atop Dermatitis, Amsterdam, Netherlands

[6] Patient Representat, Nottingham, England

[7] Kings Coll London, St Johns Inst Dermatol, London, England

[8] Womens Coll Hosp, Dept Med, Toronto, ON, Canada

[9] Womens Coll Hosp, Womens Coll, Res Inst, Toronto, ON, Canada

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 04期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1093/bjd/ljad237

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The HOME initiative has successfully completed a core outcome set for atopic dermatitis (AD) trials, and most trials now include the core set instruments. However, to enable evidence synthesis of all relevant trials, reporting must also be standardized. In this study, we evaluated the reporting of the core outcome set instruments in AD systemic treatment trials included in a living systematic review and network meta-analysis. We found that although the core instruments were measured in most trials, they were often not reported sufficiently to enable inclusion in network meta-analysis.

引用

页码：494 / 496

页数：3

共 50 条

[41] REPORTING OF CONTINUOUS OUTCOME MEASURES IN RANDOMIZED CLINICAL TRIALS: IS THE WHOLE STORY BEING TOLD?
Savage, D. F.
Schriger, D. L.
Altman, D.
JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 175 - 176
[42] Systemic Treatments for Atopic Dermatitis: Systematic Review and Network MetaAnalysis of Randomized Trials
Chu, Alexandro
Wong, Melanie
Rayner, Daniel
Guyatt, Gordon
Diaz Martinez, Juan Pablo
Ceccacci, Renata
Zhao, Irene
McMullen, Eric
Srivastava, Archita
Wang, Jason
Wen, Aaron
Wang, Fang Chi
Brignardello-Petersen, Romina
Izcovich, Ariel
Oykhman, Paul
Wheeler, Kathryn
Wang, Julie
Spergel, Jonathan
Singh, Jasvinder
Silverberg, Jonathan
Ong, Peck
O'Brien, Monica
Martin, Stephen
Lio, Peter
Lind, Mary Laura
Lebovidge, Jennifer
Kim, Elaine
Huynh, Joey
Greenhawt, Matthew
Gardner, Donna
Frazier, Winfred
Ellison, Kathy
Chen, Lina
Capozza, Korey
De Benedetto, Anna
Boguniewicz, Mark
Begolka, Wendy Smith
Asiniwasis, Rachel Netahe
Schneider, Lynda
Chu, Derek
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB69 - AB69
[43] Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials
Eleftheriadou, Viktoria
Bergqvist, Christina
Kechichian, Elio
Shourick, Jason
Ju, Hyun-Jeong
van Geel, Nanja
Bae, Jung Min
Ezzedine, Khaled
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (02) : 247 - 258
[44] Core Outcome Set for Actinic Keratosis Clinical Trials
Reynolds, Kelly A.
Schlessinger, Daniel I.
Vasic, Jelena
Iyengar, Sanjana
Qaseem, Yaqoob
Behshad, Ramona
DeHoratius, Danielle M.
Denes, Pablo
Drucker, Aaron M.
Dzubow, Leonard M.
Etzkorn, Jeremy R.
Harwood, Catherine
Kim, John Y. S.
Lee, Erica H.
Lissner, Gary S.
Marghoob, Ashfaq A.
Matin, Rubeta N.
Mattox, Adam
Mittal, Bharat B.
Thomas, J. Regan
Zhou, Xiaolong Alan
Zloty, David
Schmitt, Jochen
Kirkham, Jamie
Poon, Emily
Sobanko, Joseph F.
Cartee, Todd V.
Maher, Ian A.
Alam, Murad
JAMA DERMATOLOGY, 2020, 156 (03) : 326 - 333
[45] Development of a Core Outcome Set for Clinical Trials in Melasma
Dirr, McKenzie A.
Christensen, Rachel E.
Anvery, Noor
Hisham, Farhana Ikmal
Yi, Michael D.
Nadir, Umer
Dave, Loma
Kang, Bianca Y.
Alam, Murad
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB36 - AB36
[46] A core outcome set for clinical trials in acute diarrhoea
Karas, Jacek
Ashkenazi, Shai
Guarino, Alfredo
Lo Vecchio, Andrea
Shamir, Raanan
Vandenplas, Yvan
Szajewska, Hania
ARCHIVES OF DISEASE IN CHILDHOOD, 2015, 100 (04) : 359 - U79
[47] Outcome measures in rheumatologic clinical trials and systemic sclerosis
Furst, D. E.
RHEUMATOLOGY, 2008, 47 : V29 - V30
[48] Outcome reporting in fertility trials: what a mess! Why we need a core outcome set
Wilkinson, J.
HUMAN REPRODUCTION, 2019, 34 : 98 - 98
[49] Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: Consensus on a preliminary core set of outcome domains
Smolen, JS
Strand, V
Cardiel, M
Edworthy, S
Furst, D
Gladman, D
Gordon, C
Isenberg, DA
Klippel, JH
Petri, M
Simon, L
Tugwell, P
Wolfe, F
JOURNAL OF RHEUMATOLOGY, 1999, 26 (02) : 504 - 507
[50] Core outcome measures in effectiveness trials (COMET) initiative: an international delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'Core Outcome Set'
Prinsen, Cecilia A. C.
Vohra, Sunita
Rose, Michael R.
Terwee, Caroline B.
QUALITY OF LIFE RESEARCH, 2014, 23 : 100 - 101

← 1 2 3 4 5 →